Osiris Therapeutics, Inc., based in Columbia, Maryland, researches, develops, manufactures and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. We have achieved commercial success with products in orthopedics, sports medicine and wound care, including the Grafix® product line, Stravix®, BIO4® and Cartiform®. We continue to advance our research and development by focusing on innovation in regenerative medicine, including the development of bioengineered stem cell and tissue-based products.
GrafixPL® and Stravix® are cryopreserved and lyopreserved placental tissue for wound care and surgical applications.
Product Categories
Devices
- Wound Closure
Wound Care
- Cellular
- Tissue-based